Endo International saw the highest growth of 0.99% in patent filings in April and 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Endo International‘s patent filings and grants. Buy the databook here.
Endo International has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 50% grants. The United States(US), Australia(AU), and Spain(ES) patent Office are among the top ten patent offices where Endo International is filings its patents. Among the top granted patent authorities, Endo International has 50% of its grants in United States(US), 25% in Australia(AU) and 25% in Spain(ES).
Immatics and Aquanova could be the strongest competitors for Endo International
Patents related to climate change and rare diseases lead Endo International's portfolio
Endo International has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 67% of patents were granted in Q2 2024.
Storage related patents lead Endo International portfolio followed by general surgery devices, and cardiac arrest
Endo International has highest number of patents in storage followed by general surgery devices, cardiac arrest, septic shock, and diarrhea.
For comprehensive analysis of Endo International's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.